Year: 2025
Type: article
Abstract: Coronavirus disease 2019 (COVID-19) is associated with an increased risk of thrombotic complications. Multiple lines of evidence support the existence of a hypercoagulable state in hospitalized COVID-19 patients. Enhanced platelet activation, enhanced in vivo thrombin generation and ex vivo thrombin-generating capacity, hyperfibrinogenaemia, and ex vivo resistance to fibrinolysis have all been demonstrated.
DOI: 10.17615/nege-xd13
Authors: Mackman, Nigel, von Meijenfeldt, Fien A., Adelmeijer, Jelle, Magnusson, Maria, Havervall, Sebastian, Lundström, Annika, Lisman, Ton, Thalin, Charlotte
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4414565661
FWCI:
Cites:
Cited by:
Related to: